G. B. Melts

Effect of ritanserin, specific 5HT–2 antagonist, on PRL secretion in normal subjects and in different hyperprolactinaemic conditions *

P. Falaschi, A. Rocco, R. D’Urso, 1991, Clinical endocrinology.